{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:32:51Z","timestamp":1767598371743,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81601452"],"award-info":[{"award-number":["81601452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Youth Research Fund of Beijing Tiantan Hospital","award":["2016-YQN-02"],"award-info":[{"award-number":["2016-YQN-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11060-017-2673-8","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T02:30:55Z","timestamp":1512959455000},"page":"523-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Regional specificity of 1p\/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients"],"prefix":"10.1007","volume":"136","author":[{"given":"Kai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-6351","authenticated-orcid":false,"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cancergen.2012.10.009","volume":"205","author":"ML Goodenberger","year":"2012","unstructured":"Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205:613\u2013621. \n                        https:\/\/doi.org\/10.1016\/j.cancergen.2012.10.009","journal-title":"Cancer Genet"},{"key":"2673_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ncpneuro0289","volume":"2","author":"JA Schwartzbaum","year":"2006","unstructured":"Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2:494\u2013503. \n                        https:\/\/doi.org\/10.1038\/ncpneuro0289","journal-title":"Nat Clin Pract Neurol"},{"key":"2673_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","volume":"109","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93\u2013108. \n                        https:\/\/doi.org\/10.1007\/s00401-005-0991-y","journal-title":"Acta Neuropathol"},{"key":"2673_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research N","year":"2008","unstructured":"Cancer Genome Atlas Research N (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061\u20131068. \n                        https:\/\/doi.org\/10.1038\/nature07385","journal-title":"Nature"},{"key":"2673_CR5","first-page":"1175","volume":"145","author":"J Reifenberger","year":"1994","unstructured":"Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175\u20131190","journal-title":"Am J Pathol"},{"key":"2673_CR6","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/neuonc\/not092","volume":"15","author":"X Ren","year":"2013","unstructured":"Ren X, Jiang H, Cui X, Cui Y, Ma J, Jiang Z, Sui D, Lin S (2013) Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p\/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases. Neuro Oncol 15:1244\u20131250. \n                        https:\/\/doi.org\/10.1093\/neuonc\/not092","journal-title":"Neuro Oncol"},{"key":"2673_CR7","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1212\/01.wnl.0000262034.26310.a2","volume":"68","author":"G Kaloshi","year":"2007","unstructured":"Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K (2007) Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome. Neurology 68:1831\u20131836. \n                        https:\/\/doi.org\/10.1212\/01.wnl.0000262034.26310.a2","journal-title":"Neurology"},{"key":"2673_CR8","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.ejca.2006.05.021","volume":"42","author":"MC Kouwenhoven","year":"2006","unstructured":"Kouwenhoven MC, Kros JM, French PJ, Biemond-ter Stege EM, Graveland WJ, Taphoorn MJ, Brandes AA, van den Bent MJ (2006) 1p\/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. Eur J Cancer 42:2499\u20132503. \n                        https:\/\/doi.org\/10.1016\/j.ejca.2006.05.021","journal-title":"Eur J Cancer"},{"key":"2673_CR9","doi-asserted-by":"publisher","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","volume":"66","author":"RB Jenkins","year":"2006","unstructured":"Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852\u20139861. \n                        https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1796","journal-title":"Cancer Res"},{"key":"2673_CR10","first-page":"6713","volume":"61","author":"MC Zlatescu","year":"2001","unstructured":"Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61:6713\u20136715","journal-title":"Cancer Res"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1200\/JCO.2010.33.8715","volume":"29","author":"A Lai","year":"2011","unstructured":"Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS (2011) Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29:4482\u20134490. \n                        https:\/\/doi.org\/10.1200\/JCO.2010.33.8715","journal-title":"J Clin Oncol"},{"key":"2673_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.neuroimage.2011.09.076","volume":"59","author":"BM Ellingson","year":"2012","unstructured":"Ellingson BM, Cloughesy TF, Pope WB, Zaw TM, Phillips H, Lalezari S, Nghiemphu PL, Ibrahim H, Naeini KM, Harris RJ, Lai A (2012) Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas. Neuroimage 59:908\u2013916. \n                        https:\/\/doi.org\/10.1016\/j.neuroimage.2011.09.076","journal-title":"Neuroimage"},{"key":"2673_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9440(10)64183-1","volume":"161","author":"W Mueller","year":"2002","unstructured":"Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A (2002) Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161:313\u2013319. \n                        https:\/\/doi.org\/10.1016\/S0002-9440(10)64183-1","journal-title":"Am J Pathol"},{"key":"2673_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0360-3016(93)90203-8","volume":"26","author":"JR Simpson","year":"1993","unstructured":"Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239\u2013244","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2673_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.neuro.24.1.385","volume":"24","author":"R Wechsler-Reya","year":"2001","unstructured":"Wechsler-Reya R, Scott MP (2001) The developmental biology of brain tumors. Annu Rev Neurosci 24:385\u2013428. \n                        https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.385","journal-title":"Annu Rev Neurosci"},{"key":"2673_CR16","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3174\/ajnr.A3352","volume":"34","author":"S Fellah","year":"2013","unstructured":"Fellah S, Caudal D, De Paula AM, Dory-Lautrec P, Figarella-Branger D, Chinot O, Metellus P, Cozzone PJ, Confort-Gouny S, Ghattas B, Callot V, Girard N (2013) Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p\/19q codeletion in the pretherapeutic diagnosis? AJNR Am J Neuroradiol 34:1326\u20131333. \n                        https:\/\/doi.org\/10.3174\/ajnr.A3352","journal-title":"AJNR Am J Neuroradiol"},{"key":"2673_CR17","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/neuonc\/nos259","volume":"14","author":"NL Jansen","year":"2012","unstructured":"Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Popperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougere C, Thon N (2012) Prediction of oligodendroglial histology and LOH 1p\/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro Oncol 14:1473\u20131480. \n                        https:\/\/doi.org\/10.1093\/neuonc\/nos259","journal-title":"Neuro Oncol"},{"key":"2673_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11060-015-1737-x","volume":"122","author":"P Bourdillon","year":"2015","unstructured":"Bourdillon P, Hlaihel C, Guyotat J, Guillotton L, Honnorat J, Ducray F, Cotton F (2015) Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p\/19q codeletion status. J Neurooncol 122:529\u2013537. \n                        https:\/\/doi.org\/10.1007\/s11060-015-1737-x","journal-title":"J Neurooncol"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nn1050","volume":"6","author":"E Bates","year":"2003","unstructured":"Bates E, Wilson SM, Saygin AP, Dick F, Sereno MI, Knight RT, Dronkers NF (2003) Voxel-based lesion-symptom mapping. Nat Neurosci 6:448\u2013450. \n                        https:\/\/doi.org\/10.1038\/nn1050","journal-title":"Nat Neurosci"},{"key":"2673_CR20","doi-asserted-by":"publisher","first-page":"14681","DOI":"10.1073\/pnas.1206608109","volume":"109","author":"J Glascher","year":"2012","unstructured":"Glascher J, Adolphs R, Damasio H, Bechara A, Rudrauf D, Calamia M, Paul LK, Tranel D (2012) Lesion mapping of cognitive control and value-based decision making in the prefrontal cortex. Proc Natl Acad Sci USA 109:14681\u201314686. \n                        https:\/\/doi.org\/10.1073\/pnas.1206608109","journal-title":"Proc Natl Acad Sci USA"},{"key":"2673_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1162\/jocn.2007.19.7.1067","volume":"19","author":"DY Kimberg","year":"2007","unstructured":"Kimberg DY, Coslett HB, Schwartz MF (2007) Power in voxel-based lesion-symptom mapping. J Cogn Neurosci 19:1067\u20131080. \n                        https:\/\/doi.org\/10.1162\/jocn.2007.19.7.1067","journal-title":"J Cogn Neurosci"},{"key":"2673_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuropsychologia.2009.09.016","volume":"48","author":"J Medina","year":"2010","unstructured":"Medina J, Kimberg DY, Chatterjee A, Coslett HB (2010) Inappropriate usage of the Brunner-Munzel test in recent voxel-based lesion-symptom mapping studies. Neuropsychologia 48:341\u2013343. \n                        https:\/\/doi.org\/10.1016\/j.neuropsychologia.2009.09.016","journal-title":"Neuropsychologia"},{"key":"2673_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3174\/ajnr.A2950","volume":"33","author":"JA Carrillo","year":"2012","unstructured":"Carrillo JA, Lai A, Nghiemphu PL, Kim HJ, Phillips HS, Kharbanda S, Moftakhar P, Lalaezari S, Yong W, Ellingson BM, Cloughesy TF, Pope WB (2012) Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. AJNR Am J Neuroradiol 33:1349\u20131355. \n                        https:\/\/doi.org\/10.3174\/ajnr.A2950","journal-title":"AJNR Am J Neuroradiol"},{"key":"2673_CR24","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1021\/pr100054v","volume":"9","author":"RC Rostomily","year":"2010","unstructured":"Rostomily RC, Born DE, Beyer RP, Jin J, Alvord EC Jr, Mikheev AM, Matthews RT, Pan C, Khorasani L, Sonnen JA, Montine TJ, Shi M, Zhang J (2010) Quantitative proteomic analysis of oligodendrogliomas with and without 1p\/19q deletion. J Proteome Res 9:2610\u20132618. \n                        https:\/\/doi.org\/10.1021\/pr100054v","journal-title":"J Proteome Res"},{"key":"2673_CR25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mpo.1242","volume":"37","author":"PF Ambros","year":"2001","unstructured":"Ambros PF, Ambros IM, Europe Neuroblastoma Pathology SIOP. \"Biology, and Bone Marrow Group (2001) Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37:492\u2013504","journal-title":"Med Pediatr Oncol"},{"key":"2673_CR26","doi-asserted-by":"publisher","first-page":"e32764","DOI":"10.1371\/journal.pone.0032764","volume":"7","author":"X Ren","year":"2012","unstructured":"Ren X, Cui X, Lin S, Wang J, Jiang Z, Sui D, Li J, Wang Z (2012) Co-deletion of chromosome 1p\/19q and IDH1\/2 mutation in glioma subsets of brain tumors in Chinese patients. PLoS ONE 7:e32764. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0032764","journal-title":"PLoS ONE"},{"key":"2673_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3174\/ajnr.A4065","volume":"36","author":"YY Wang","year":"2015","unstructured":"Wang YY, Zhang T, Li SW, Qian TY, Fan X, Peng XX, Ma J, Wang L, Jiang T (2015) Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis. AJNR Am J Neuroradiol 36:70\u201376. \n                        https:\/\/doi.org\/10.3174\/ajnr.A4065","journal-title":"AJNR Am J Neuroradiol"},{"key":"2673_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11060-012-0831-6","volume":"108","author":"C Goze","year":"2012","unstructured":"Goze C, Bezzina C, Goze E, Rigau V, Maudelonde T, Bauchet L, Duffau H (2012) 1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth. J Neurooncol 108:69\u201375. \n                        https:\/\/doi.org\/10.1007\/s11060-012-0831-6","journal-title":"J Neurooncol"},{"key":"2673_CR29","first-page":"839","volume":"7","author":"Y Ino","year":"2001","unstructured":"Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839\u2013845","journal-title":"Clin Cancer Res"},{"key":"2673_CR30","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/brain\/awl108","volume":"129","author":"MD Jenkinson","year":"2006","unstructured":"Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C (2006) Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 129:1884\u20131891. \n                        https:\/\/doi.org\/10.1093\/brain\/awl108","journal-title":"Brain"},{"key":"2673_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/neuonc\/not235","volume":"16","author":"G Reyes-Botero","year":"2014","unstructured":"Reyes-Botero G, Dehais C, Idbaih A, Martin-Duverneuil N, Lahutte M, Carpentier C, Letouze E, Chinot O, Loiseau H, Honnorat J, Ramirez C, Moyal E, Figarella-Branger D, Ducray F, Network P (2014) Contrast enhancement in 1p\/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Neuro Oncol 16:662\u2013670. \n                        https:\/\/doi.org\/10.1093\/neuonc\/not235","journal-title":"Neuro Oncol"},{"key":"2673_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1215\/15228517-2009-011","volume":"11","author":"MC Kouwenhoven","year":"2009","unstructured":"Kouwenhoven MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L, Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ (2009) Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: a report from EORTC study 26951. Neuro Oncol 11:737\u2013746. \n                        https:\/\/doi.org\/10.1215\/15228517-2009-011","journal-title":"Neuro Oncol"},{"key":"2673_CR33","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/cncr.11187","volume":"97","author":"MJ Bent van den","year":"2003","unstructured":"van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM (2003) Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer 97:1276\u20131284. \n                        https:\/\/doi.org\/10.1002\/cncr.11187","journal-title":"Cancer"},{"issue":"Suppl 4","key":"2673_CR34","doi-asserted-by":"publisher","first-page":"iv100","DOI":"10.1093\/neuonc\/nos206","volume":"14","author":"M Weller","year":"2012","unstructured":"Weller M, Stupp R, Hegi ME, van den Bent M, Tonn JC, Sanson M, Wick W, Reifenberger G (2012) Personalized care in neuro-oncology coming of age: why we need MGMT and 1p\/19q testing for malignant glioma patients in clinical practice. Neuro Oncol 14(Suppl 4):iv100\u2013iv108. \n                        https:\/\/doi.org\/10.1093\/neuonc\/nos206","journal-title":"Neuro Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2673-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T12:33:07Z","timestamp":1518093187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2673-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2673-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}